Latest Malin News & Updates

See the latest news and media coverage for Malin. We track all announcements, press releases, and industry mentions in real time, all in one place.

Malin

Publicly listed life sciences investment company

malinplc.com

Headquarters: Dublin 2, Ireland
Founded year: 2015
Company type: Public company
Number of employees: 11–50
Industry: Investment Holding Companies

Last updated October 23

Latest news about Malin

In short: Malin wrote off Viamet, missed $25.9m earnout and reported €9.36 per-share value

Company announcements

August 26 Malin

Malin reports its 2026 interim financial results and valuations

The company discloses an estimated intrinsic equity value of €9.36 per share at mid-year and details changes in its investment portfolio including Poseida and Kymab.

July 24 Malin

Malin investee Sanofi discontinues amlitelimab in atopic dermatitis

The decision follows a strategic assessment; safety and efficacy data did not show meaningful improvement over standard of care. No impact on Sanofi's 2026 guidance.

January 23 Malin

Sanofi announces positive phase 3 results for amlitelimab

Amlitelimab met key endpoints in SHORE and COAST 2 studies for atopic dermatitis treatment. Sanofi plans global regulatory submissions in H2 2026.

November 18, 2025 Malin

Mycovia announces publication of 2-year VIVJOA efficacy results

The VIOLET Phase 3 extension study showed 98% of women remained infection-free versus 82% on placebo for nearly two years. VIVJOA is FDA-approved for RVVC in non-reproductive potential women.

Media coverage

October 23 Morningstar

Iseq ends trading up over 2.8%, with Malin and Bank of Ireland leading the gains

February was a month of two halves for investors on Revolut's platform in Ireland,...

Never miss news about Malin

Track Malin and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Malin competitors & trending companies

Browse news for competitors to Malin and other trending companies.